Medication-Induced Lupus Symptoms and Treatment

In addition to your ANA test results, your doctor will look at many different pieces of information, like your symptoms, medical history, and family history. They may also ask you to take more blood tests to check for different kinds of antibodies in your blood. Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease where the immune system mistakenly attacks healthy tissues. It can affect multiple organs, including the skin, joints, kidneys, heart, and brain. Some medications that are structurally similar to the initial offending drug could pose a similar risk. Patients should inform all healthcare providers of their history with DIL to prevent unintentional re-exposure.

How quickly does drug-induced lupus develop?

It is a rare condition that affects infants of women who have lupus and is caused by antibodies from the mother acting upon the infant in the womb. • Blood and blood vessels – May lead to anemia (reduced number of healthy red blood cells) and increased risk of bleeding or blood clotting. According to nationwide surveys conducted by the Lupus Foundation of America, an estimated 1.5 million Americans are affected by some form of lupus. While the disease can occur in both men and women of all ages, it is 10 to 15 times more common in adult females and most often develops between the ages of 15 and 44. The exact cause of lupus remains unknown, but researchers believe that genetic factors may make some individuals more susceptible to the disease.

Cell death signaling

  • The women did not have anemia, active SLE, or other conditions that would cause debilitation.
  • Regular side effects, on the other hand, usually come on soon after you start taking a new medication.
  • Early detection can help prevent permanent tissue or organ damage and may reduce the need for high-dose medications.
  • Patients should inform all healthcare providers of their history with DIL to prevent unintentional re-exposure.
  • Other autoantibodies against antigens including smith, ribonuclear protein (RNP), SCL70, centromere, Jo-1 are rare in DIL and may help differentiate DIL from other autoimmune disorders.

Environmental triggers such as infections, certain medications, ultraviolet light exposure, extreme stress, and antibiotics are also thought to play a significant role in its development. Antinuclear Disorder also known as ANA – this is positive in most (95%) people with lupus, but can also be positive with other diseases and in healthy people. Lupus can be difficult to diagnose as the symptoms come and go and mimic many other illnesses. The most commonly diagnosed type of lupus, can affect the skin, joints lungs kidneys, heart, blood vessels, nervous system and brain.

what is drug-induced lupus lupus foundation of america

When lupus makes your immune system attack healthy tissue, it can cause inflammation in lots of different body parts. Some recent studies suggest that novel genetic mutations and epigenetic factors may influence lupus risk. Additionally, researchers are investigating the role of gut microbiota in immune system regulation and lupus development.

Drug-Induced Lupus Erythematosus

Immunologic Disorder – Blood test which shows a positive anti-double stranded DNA test, positive anti-Sm (antibody to ribonucleoprotein), anti-Ro (SSA), anti LA (SSB), or a false positive syphillis test (VDRI). Or skin is limited to the skin and is identified by a rash that may appear on the face, the scalp or neck. The National Lupus Foundation estimates 10% of all cases of lupus are discoid. It’s more likely to develop in White people than African-Americans, as well. Laboratory evaluation shall also include evaluation of complements (C3 and C4), renal function including urine to evaluate for proteinuria, liver function.

This will make it easier to explain to your physician the nature of any medication side effects that you experience. Never abruptly stop taking a prescribed medication without first talking to your physician. A healthy dialogue can result in better medical care for anyone seeking medical treatment.

Personalized Medicine in Lupus

  • It’s important to note that Drug-Induced Lupus (DIL) symptoms usually develop after long-term use of certain medications, often within weeks to months.
  • Drug-induced lupus carries a favorable prognosis with less morbidity and mortality as compared to SLE.
  • Hundreds of drugs have been reported to cause DIL.23 While some drugs have good evidence of association with DIL, there are case reports implicating several other drugs as a possible cause of DIL.

Drug-induced lupus erythematosus (DIL) is an autoimmune phenomenon where the patient develops symptoms similar to systemic lupus erythematosus (SLE) after exposure to certain drugs. While DIL tends to be less severe than SLE, the diagnosis can be challenging. This activity reviews the pathophysiology and management of drug-induced lupus and highlights the role of the interprofessional team in its management. Treating Drug-Induced Lupus (DIL) focuses on stopping the medication that caused the condition and managing symptoms to improve the patient’s comfort and well-being. While most symptoms resolve after discontinuing the drug, additional therapies like anti-inflammatory medications or, in severe cases, immunosuppressive treatments may be needed to control pain and inflammation. There are several categories of drugs used to treat lupus, but only a few are specifically approved by the FDA for this condition.

Differential Diagnosis

Various organizations worldwide provide support, resources, and research funding for lupus patients, helping them manage the disease more effectively. Advancements in personalized medicine are helping tailor lupus treatments to individual patients based on genetic and clinical profiles. Researchers are studying how genetic variations affect drug metabolism and response, leading to more precise treatment options.

Lupus is a complex and often misunderstood autoimmune disease that affects millions of people worldwide. According to the Lupus Foundation of America, at least 5 million people live with some form of lupus globally, with Systemic Lupus Erythematosus (SLE) being the most common and severe type. The prognosis for DIL is generally much more favorable than that of SLE. While SLE is a chronic autoimmune disorder that can lead to long-term complications and requires ongoing treatment, DIL usually resolves without lasting damage after stopping the triggering medication. Additionally, DIL does not typically involve major organs, such as the kidneys or brain, which are more commonly affected in SLE. Most patients experience full recovery from DIL after stopping the offending medication.

Prognosis and Patient Outcomes

The pathological examination of the biopsy from the skin rash in patients with DIL is similar to those with SLE. Inhibition of DNA methylation is thought to contribute to the development of DIL from many agents including procainamide and hydralazine. The demethylation of CD4+ T cells makes them autoreactive by overexpression of the LFA-1 adhesion molecule. This autoantibody production and release of the antigenic macrophage chromatin is thought to contribute to the development of lupus-like autoimmunity. Painless passage of blood or protein in the urine may often be the only presenting sign of kidney involvement.

Since DIL symptoms can closely resemble those of other types of lupus, healthcare professionals need to evaluate the patient’s medication use, particularly drugs known to induce DIL. DIL differs from other forms of lupus, such as cutaneous lupus, which primarily affects the skin, and SLE, which can affect multiple organs. Medications commonly linked to DIL include hydralazine (used for high blood pressure), procainamide (for heart issues), and isoniazid (an antibiotic for tuberculosis). The prognosis for patients with drug-induced lupus is generally very favorable.

While DIL can be a severe and debilitating illness that’s hard to diagnose, the good news is that what is drug-induced lupus lupus foundation of america it can be cured by going off the drug that triggered it. People with DIL caused by quinidine or hydralazine may have negative ANA results.